Skip to content
Portage Biotech
Portage BiotechPortage Biotech
  • about us
    • overview
    • leadership
  • our pipeline
    • iNKT platform
    • adenosine platform
    • other programs in development
  • news
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • join our team
  • contact
  • about us
    • overview
    • leadership
  • our pipeline
    • iNKT platform
    • adenosine platform
    • other programs in development
  • news
  • investors
    • overview
    • stock information
    • news releases
    • investor calendar
    • presentations & publications
    • sec filings
    • financial & regulatory reports
    • corporate governance
    • investor faqs
  • join our team
  • contact

Category Archives: Press Release

Portage Biotech Provides Update on Clinical-Stage and Development Programs

Press ReleaseBy Gwen SchankerMarch 31, 2022
...

Portage Biotech Announces Presentation of PORT-5 (STI-001) Late-Breaking Data at AACR 2022 Annual Meeting

Press ReleaseBy Gwen SchankerMarch 9, 2022
...

Portage Biotech Announces Financial Results and Provides Business Update for Third Quarter of 2022 Fiscal Year

Press ReleaseBy Gwen SchankerFebruary 24, 2022
...

Portage Biotech Announces New Appointments to its Management Team and Board of Directors

Press ReleaseBy Gwen SchankerFebruary 15, 2022
...

Portage Biotech Announces Participation in January 2022 Investor Conferences

Press ReleaseBy Gwen SchankerJanuary 5, 2022
...

Portage Biotech Announces Financial Results and Provides Business Update for Second Quarter of 2022 Fiscal Year

Press ReleaseBy Portage Biotech, IncNovember 23, 2021
...

Portage Biotech to Present at the Piper Sandler 33rd Annual Healthcare Conference

Press ReleaseBy Portage Biotech, IncNovember 22, 2021
...

Portage Biotech Highlights Promising Efficacy and Survival Data Presented on Intensity Therapeutics’ INT230-6 (PORT-1) at November Scientific Conferences

Press ReleaseBy Portage Biotech, IncNovember 15, 2021
...

Portage Biotech Hosting Key Opinion Leader Webinar on How iNKT Agonists Could Improve Immuno-Oncology Treatment

Press ReleaseBy Portage Biotech, IncNovember 10, 2021
...

Portage Biotech Announces Participation in September 2021 Investor Conferences

Press ReleaseBy Portage Biotech, IncSeptember 10, 2021
...
→12345…
6789101112
13→
Copyright © All rights reserved Portage Biotech, Inc

terms of use   privacy policy   disclaimer

Go to Top